Global Artificial Intelligence Drug R&D Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Artificial Intelligence Drug R&D market size was valued at US$ 751 million in 2025 and is forecast to a readjusted size of US$ 1325 million by 2032 with a CAGR of 7.9% during review period.
Artificial Intelligence Drug R&D (AI Drug Development) refers to a class of R&D methods and software/platform systems that utilize technologies such as machine learning, deep learning, generative models, and knowledge graphs to model and infer multi-omics and biomedical data throughout the entire drug development process, from target discovery to lead compounds, preclinical trials, clinical trials, and post-marketing. This aims to improve the accuracy of target selection, shorten the candidate drug discovery cycle, reduce the failure rate, and optimize trial design and patient stratification.
AI-driven drug development is transitioning from 'proof of concept' to 'deliverable productivity.' On one hand, large pharmaceutical companies and platform companies are emphasizing interpretability, auditability, and compliance (GxP/data governance), embedding AI models into existing experimental automation, LIMS/ELN, cheminformatics, and clinical operations systems to form an 'AI + experimental closed loop' (design–make–test–analyze). On the other hand, industry focus is shifting from single-point tools to end-to-end capabilities: for example, integrating target selection, molecular generation, ADMET, and clinical strategies, while enhancing model generalization capabilities through multimodal data (omics, imaging, EHR, literature, and patents), making AI more closely aligned with real-world R&D decisions.
Simultaneously, generative AI is reshaping the workflow of early-stage research and translational medicine: at the molecular and protein level, the combination of generation and screening (virtual screening + de novo design) is becoming more common; at the clinical level, real-world data and patient stratification are driving 'more precise enrollment and endpoint selection' to reduce trial size or increase success rates. In terms of commercialization, the cooperation model has expanded from 'software subscription' to 'milestone/revenue sharing, joint R&D, and joint pipeline incubation', and places greater emphasis on quantifiable deliverables (hit rate, shortened cycle, candidate quality) and reproducible verification system.
This report is a detailed and comprehensive analysis for global Artificial Intelligence Drug R&D market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Artificial Intelligence Drug R&D market size and forecasts, in consumption value ($ Million), 2021-2032
Global Artificial Intelligence Drug R&D market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Artificial Intelligence Drug R&D market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Artificial Intelligence Drug R&D market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Artificial Intelligence Drug R&D
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Artificial Intelligence Drug R&D market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Insilico Medicine, Recursion, BenevolentAI, Atomwise, Recursion Pharmaceuticals, DeepMind?Google?, Insitro, Owkin, XtalPi, Verge Genomics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Artificial Intelligence Drug R&D market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Artificial Intelligence Drug R&D product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Artificial Intelligence Drug R&D, with revenue, gross margin, and global market share of Artificial Intelligence Drug R&D from 2021 to 2026.
Chapter 3, the Artificial Intelligence Drug R&D competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Artificial Intelligence Drug R&D market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Intelligence Drug R&D.
Chapter 13, to describe Artificial Intelligence Drug R&D research findings and conclusion.
Artificial Intelligence Drug R&D (AI Drug Development) refers to a class of R&D methods and software/platform systems that utilize technologies such as machine learning, deep learning, generative models, and knowledge graphs to model and infer multi-omics and biomedical data throughout the entire drug development process, from target discovery to lead compounds, preclinical trials, clinical trials, and post-marketing. This aims to improve the accuracy of target selection, shorten the candidate drug discovery cycle, reduce the failure rate, and optimize trial design and patient stratification.
AI-driven drug development is transitioning from 'proof of concept' to 'deliverable productivity.' On one hand, large pharmaceutical companies and platform companies are emphasizing interpretability, auditability, and compliance (GxP/data governance), embedding AI models into existing experimental automation, LIMS/ELN, cheminformatics, and clinical operations systems to form an 'AI + experimental closed loop' (design–make–test–analyze). On the other hand, industry focus is shifting from single-point tools to end-to-end capabilities: for example, integrating target selection, molecular generation, ADMET, and clinical strategies, while enhancing model generalization capabilities through multimodal data (omics, imaging, EHR, literature, and patents), making AI more closely aligned with real-world R&D decisions.
Simultaneously, generative AI is reshaping the workflow of early-stage research and translational medicine: at the molecular and protein level, the combination of generation and screening (virtual screening + de novo design) is becoming more common; at the clinical level, real-world data and patient stratification are driving 'more precise enrollment and endpoint selection' to reduce trial size or increase success rates. In terms of commercialization, the cooperation model has expanded from 'software subscription' to 'milestone/revenue sharing, joint R&D, and joint pipeline incubation', and places greater emphasis on quantifiable deliverables (hit rate, shortened cycle, candidate quality) and reproducible verification system.
This report is a detailed and comprehensive analysis for global Artificial Intelligence Drug R&D market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Artificial Intelligence Drug R&D market size and forecasts, in consumption value ($ Million), 2021-2032
Global Artificial Intelligence Drug R&D market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Artificial Intelligence Drug R&D market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Artificial Intelligence Drug R&D market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Artificial Intelligence Drug R&D
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Artificial Intelligence Drug R&D market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Insilico Medicine, Recursion, BenevolentAI, Atomwise, Recursion Pharmaceuticals, DeepMind?Google?, Insitro, Owkin, XtalPi, Verge Genomics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Artificial Intelligence Drug R&D market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Software
- Service
- Target Identification & Validation
- Hit/Lead Discovery
- Clinical Development & Trial Design
- Others
- Machine Learning & Deep Learning
- Generative Models
- Knowledge Graph & NLP
- Multi-omics / Multimodal Modeling
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations?CRO)
- Academic & Research Institutions
- Others
- Insilico Medicine
- Recursion
- BenevolentAI
- Atomwise
- Recursion Pharmaceuticals
- DeepMind?Google?
- Insitro
- Owkin
- XtalPi
- Verge Genomics
- Iktos
- Valo Health
- Standigm
- Relay Therapeutics
- Cyclica
- Isomorphic Labs
- Schr?dinger
- Absci
- Genesis Therapeutics
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Artificial Intelligence Drug R&D product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Artificial Intelligence Drug R&D, with revenue, gross margin, and global market share of Artificial Intelligence Drug R&D from 2021 to 2026.
Chapter 3, the Artificial Intelligence Drug R&D competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Artificial Intelligence Drug R&D market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Intelligence Drug R&D.
Chapter 13, to describe Artificial Intelligence Drug R&D research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Artificial Intelligence Drug R&D by Type
1.3.1 Overview: Global Artificial Intelligence Drug R&D Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Artificial Intelligence Drug R&D Consumption Value Market Share by Type in 2025
1.3.3 Software
1.3.4 Service
1.4 Classification of Artificial Intelligence Drug R&D by Stage
1.4.1 Overview: Global Artificial Intelligence Drug R&D Market Size by Stage: 2021 Versus 2025 Versus 2032
1.4.2 Global Artificial Intelligence Drug R&D Consumption Value Market Share by Stage in 2025
1.4.3 Target Identification & Validation
1.4.4 Hit/Lead Discovery
1.4.5 Clinical Development & Trial Design
1.4.6 Others
1.5 Classification of Artificial Intelligence Drug R&D by Technology
1.5.1 Overview: Global Artificial Intelligence Drug R&D Market Size by Technology: 2021 Versus 2025 Versus 2032
1.5.2 Global Artificial Intelligence Drug R&D Consumption Value Market Share by Technology in 2025
1.5.3 Machine Learning & Deep Learning
1.5.4 Generative Models
1.5.5 Knowledge Graph & NLP
1.5.6 Multi-omics / Multimodal Modeling
1.6 Global Artificial Intelligence Drug R&D Market by Application
1.6.1 Overview: Global Artificial Intelligence Drug R&D Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Pharmaceutical Companies
1.6.3 Biotechnology Companies
1.6.4 Contract Research Organizations(CRO)
1.6.5 Academic & Research Institutions
1.6.6 Others
1.7 Global Artificial Intelligence Drug R&D Market Size & Forecast
1.8 Global Artificial Intelligence Drug R&D Market Size and Forecast by Region
1.8.1 Global Artificial Intelligence Drug R&D Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Artificial Intelligence Drug R&D Market Size by Region, (2021-2032)
1.8.3 North America Artificial Intelligence Drug R&D Market Size and Prospect (2021-2032)
1.8.4 Europe Artificial Intelligence Drug R&D Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Artificial Intelligence Drug R&D Market Size and Prospect (2021-2032)
1.8.6 South America Artificial Intelligence Drug R&D Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Artificial Intelligence Drug R&D Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Insilico Medicine
2.1.1 Insilico Medicine Details
2.1.2 Insilico Medicine Major Business
2.1.3 Insilico Medicine Artificial Intelligence Drug R&D Product and Solutions
2.1.4 Insilico Medicine Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Insilico Medicine Recent Developments and Future Plans
2.2 Recursion
2.2.1 Recursion Details
2.2.2 Recursion Major Business
2.2.3 Recursion Artificial Intelligence Drug R&D Product and Solutions
2.2.4 Recursion Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Recursion Recent Developments and Future Plans
2.3 BenevolentAI
2.3.1 BenevolentAI Details
2.3.2 BenevolentAI Major Business
2.3.3 BenevolentAI Artificial Intelligence Drug R&D Product and Solutions
2.3.4 BenevolentAI Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 BenevolentAI Recent Developments and Future Plans
2.4 Atomwise
2.4.1 Atomwise Details
2.4.2 Atomwise Major Business
2.4.3 Atomwise Artificial Intelligence Drug R&D Product and Solutions
2.4.4 Atomwise Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Atomwise Recent Developments and Future Plans
2.5 Recursion Pharmaceuticals
2.5.1 Recursion Pharmaceuticals Details
2.5.2 Recursion Pharmaceuticals Major Business
2.5.3 Recursion Pharmaceuticals Artificial Intelligence Drug R&D Product and Solutions
2.5.4 Recursion Pharmaceuticals Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Recursion Pharmaceuticals Recent Developments and Future Plans
2.6 DeepMind(Google)
2.6.1 DeepMind(Google) Details
2.6.2 DeepMind(Google) Major Business
2.6.3 DeepMind(Google) Artificial Intelligence Drug R&D Product and Solutions
2.6.4 DeepMind(Google) Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 DeepMind(Google) Recent Developments and Future Plans
2.7 Insitro
2.7.1 Insitro Details
2.7.2 Insitro Major Business
2.7.3 Insitro Artificial Intelligence Drug R&D Product and Solutions
2.7.4 Insitro Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Insitro Recent Developments and Future Plans
2.8 Owkin
2.8.1 Owkin Details
2.8.2 Owkin Major Business
2.8.3 Owkin Artificial Intelligence Drug R&D Product and Solutions
2.8.4 Owkin Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Owkin Recent Developments and Future Plans
2.9 XtalPi
2.9.1 XtalPi Details
2.9.2 XtalPi Major Business
2.9.3 XtalPi Artificial Intelligence Drug R&D Product and Solutions
2.9.4 XtalPi Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 XtalPi Recent Developments and Future Plans
2.10 Verge Genomics
2.10.1 Verge Genomics Details
2.10.2 Verge Genomics Major Business
2.10.3 Verge Genomics Artificial Intelligence Drug R&D Product and Solutions
2.10.4 Verge Genomics Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Verge Genomics Recent Developments and Future Plans
2.11 Iktos
2.11.1 Iktos Details
2.11.2 Iktos Major Business
2.11.3 Iktos Artificial Intelligence Drug R&D Product and Solutions
2.11.4 Iktos Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Iktos Recent Developments and Future Plans
2.12 Valo Health
2.12.1 Valo Health Details
2.12.2 Valo Health Major Business
2.12.3 Valo Health Artificial Intelligence Drug R&D Product and Solutions
2.12.4 Valo Health Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Valo Health Recent Developments and Future Plans
2.13 Standigm
2.13.1 Standigm Details
2.13.2 Standigm Major Business
2.13.3 Standigm Artificial Intelligence Drug R&D Product and Solutions
2.13.4 Standigm Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Standigm Recent Developments and Future Plans
2.14 Relay Therapeutics
2.14.1 Relay Therapeutics Details
2.14.2 Relay Therapeutics Major Business
2.14.3 Relay Therapeutics Artificial Intelligence Drug R&D Product and Solutions
2.14.4 Relay Therapeutics Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Relay Therapeutics Recent Developments and Future Plans
2.15 Cyclica
2.15.1 Cyclica Details
2.15.2 Cyclica Major Business
2.15.3 Cyclica Artificial Intelligence Drug R&D Product and Solutions
2.15.4 Cyclica Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Cyclica Recent Developments and Future Plans
2.16 Isomorphic Labs
2.16.1 Isomorphic Labs Details
2.16.2 Isomorphic Labs Major Business
2.16.3 Isomorphic Labs Artificial Intelligence Drug R&D Product and Solutions
2.16.4 Isomorphic Labs Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Isomorphic Labs Recent Developments and Future Plans
2.17 Schrodinger
2.17.1 Schrodinger Details
2.17.2 Schrodinger Major Business
2.17.3 Schrodinger Artificial Intelligence Drug R&D Product and Solutions
2.17.4 Schrodinger Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Schrodinger Recent Developments and Future Plans
2.18 Absci
2.18.1 Absci Details
2.18.2 Absci Major Business
2.18.3 Absci Artificial Intelligence Drug R&D Product and Solutions
2.18.4 Absci Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Absci Recent Developments and Future Plans
2.19 Genesis Therapeutics
2.19.1 Genesis Therapeutics Details
2.19.2 Genesis Therapeutics Major Business
2.19.3 Genesis Therapeutics Artificial Intelligence Drug R&D Product and Solutions
2.19.4 Genesis Therapeutics Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Genesis Therapeutics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Artificial Intelligence Drug R&D Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Artificial Intelligence Drug R&D by Company Revenue
3.2.2 Top 3 Artificial Intelligence Drug R&D Players Market Share in 2025
3.2.3 Top 6 Artificial Intelligence Drug R&D Players Market Share in 2025
3.3 Artificial Intelligence Drug R&D Market: Overall Company Footprint Analysis
3.3.1 Artificial Intelligence Drug R&D Market: Region Footprint
3.3.2 Artificial Intelligence Drug R&D Market: Company Product Type Footprint
3.3.3 Artificial Intelligence Drug R&D Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Artificial Intelligence Drug R&D Consumption Value and Market Share by Type (2021-2026)
4.2 Global Artificial Intelligence Drug R&D Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2021-2026)
5.2 Global Artificial Intelligence Drug R&D Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Artificial Intelligence Drug R&D Consumption Value by Type (2021-2032)
6.2 North America Artificial Intelligence Drug R&D Market Size by Application (2021-2032)
6.3 North America Artificial Intelligence Drug R&D Market Size by Country
6.3.1 North America Artificial Intelligence Drug R&D Consumption Value by Country (2021-2032)
6.3.2 United States Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
6.3.3 Canada Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
6.3.4 Mexico Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Artificial Intelligence Drug R&D Consumption Value by Type (2021-2032)
7.2 Europe Artificial Intelligence Drug R&D Consumption Value by Application (2021-2032)
7.3 Europe Artificial Intelligence Drug R&D Market Size by Country
7.3.1 Europe Artificial Intelligence Drug R&D Consumption Value by Country (2021-2032)
7.3.2 Germany Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
7.3.3 France Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
7.3.5 Russia Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
7.3.6 Italy Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region
8.3.1 Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Region (2021-2032)
8.3.2 China Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
8.3.3 Japan Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
8.3.4 South Korea Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
8.3.5 India Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
8.3.7 Australia Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Artificial Intelligence Drug R&D Consumption Value by Type (2021-2032)
9.2 South America Artificial Intelligence Drug R&D Consumption Value by Application (2021-2032)
9.3 South America Artificial Intelligence Drug R&D Market Size by Country
9.3.1 South America Artificial Intelligence Drug R&D Consumption Value by Country (2021-2032)
9.3.2 Brazil Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
9.3.3 Argentina Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country
10.3.1 Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Country (2021-2032)
10.3.2 Turkey Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
10.3.4 UAE Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Artificial Intelligence Drug R&D Market Drivers
11.2 Artificial Intelligence Drug R&D Market Restraints
11.3 Artificial Intelligence Drug R&D Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Artificial Intelligence Drug R&D Industry Chain
12.2 Artificial Intelligence Drug R&D Upstream Analysis
12.3 Artificial Intelligence Drug R&D Midstream Analysis
12.4 Artificial Intelligence Drug R&D Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Artificial Intelligence Drug R&D by Type
1.3.1 Overview: Global Artificial Intelligence Drug R&D Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Artificial Intelligence Drug R&D Consumption Value Market Share by Type in 2025
1.3.3 Software
1.3.4 Service
1.4 Classification of Artificial Intelligence Drug R&D by Stage
1.4.1 Overview: Global Artificial Intelligence Drug R&D Market Size by Stage: 2021 Versus 2025 Versus 2032
1.4.2 Global Artificial Intelligence Drug R&D Consumption Value Market Share by Stage in 2025
1.4.3 Target Identification & Validation
1.4.4 Hit/Lead Discovery
1.4.5 Clinical Development & Trial Design
1.4.6 Others
1.5 Classification of Artificial Intelligence Drug R&D by Technology
1.5.1 Overview: Global Artificial Intelligence Drug R&D Market Size by Technology: 2021 Versus 2025 Versus 2032
1.5.2 Global Artificial Intelligence Drug R&D Consumption Value Market Share by Technology in 2025
1.5.3 Machine Learning & Deep Learning
1.5.4 Generative Models
1.5.5 Knowledge Graph & NLP
1.5.6 Multi-omics / Multimodal Modeling
1.6 Global Artificial Intelligence Drug R&D Market by Application
1.6.1 Overview: Global Artificial Intelligence Drug R&D Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Pharmaceutical Companies
1.6.3 Biotechnology Companies
1.6.4 Contract Research Organizations(CRO)
1.6.5 Academic & Research Institutions
1.6.6 Others
1.7 Global Artificial Intelligence Drug R&D Market Size & Forecast
1.8 Global Artificial Intelligence Drug R&D Market Size and Forecast by Region
1.8.1 Global Artificial Intelligence Drug R&D Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Artificial Intelligence Drug R&D Market Size by Region, (2021-2032)
1.8.3 North America Artificial Intelligence Drug R&D Market Size and Prospect (2021-2032)
1.8.4 Europe Artificial Intelligence Drug R&D Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Artificial Intelligence Drug R&D Market Size and Prospect (2021-2032)
1.8.6 South America Artificial Intelligence Drug R&D Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Artificial Intelligence Drug R&D Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Insilico Medicine
2.1.1 Insilico Medicine Details
2.1.2 Insilico Medicine Major Business
2.1.3 Insilico Medicine Artificial Intelligence Drug R&D Product and Solutions
2.1.4 Insilico Medicine Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Insilico Medicine Recent Developments and Future Plans
2.2 Recursion
2.2.1 Recursion Details
2.2.2 Recursion Major Business
2.2.3 Recursion Artificial Intelligence Drug R&D Product and Solutions
2.2.4 Recursion Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Recursion Recent Developments and Future Plans
2.3 BenevolentAI
2.3.1 BenevolentAI Details
2.3.2 BenevolentAI Major Business
2.3.3 BenevolentAI Artificial Intelligence Drug R&D Product and Solutions
2.3.4 BenevolentAI Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 BenevolentAI Recent Developments and Future Plans
2.4 Atomwise
2.4.1 Atomwise Details
2.4.2 Atomwise Major Business
2.4.3 Atomwise Artificial Intelligence Drug R&D Product and Solutions
2.4.4 Atomwise Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Atomwise Recent Developments and Future Plans
2.5 Recursion Pharmaceuticals
2.5.1 Recursion Pharmaceuticals Details
2.5.2 Recursion Pharmaceuticals Major Business
2.5.3 Recursion Pharmaceuticals Artificial Intelligence Drug R&D Product and Solutions
2.5.4 Recursion Pharmaceuticals Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Recursion Pharmaceuticals Recent Developments and Future Plans
2.6 DeepMind(Google)
2.6.1 DeepMind(Google) Details
2.6.2 DeepMind(Google) Major Business
2.6.3 DeepMind(Google) Artificial Intelligence Drug R&D Product and Solutions
2.6.4 DeepMind(Google) Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 DeepMind(Google) Recent Developments and Future Plans
2.7 Insitro
2.7.1 Insitro Details
2.7.2 Insitro Major Business
2.7.3 Insitro Artificial Intelligence Drug R&D Product and Solutions
2.7.4 Insitro Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Insitro Recent Developments and Future Plans
2.8 Owkin
2.8.1 Owkin Details
2.8.2 Owkin Major Business
2.8.3 Owkin Artificial Intelligence Drug R&D Product and Solutions
2.8.4 Owkin Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Owkin Recent Developments and Future Plans
2.9 XtalPi
2.9.1 XtalPi Details
2.9.2 XtalPi Major Business
2.9.3 XtalPi Artificial Intelligence Drug R&D Product and Solutions
2.9.4 XtalPi Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 XtalPi Recent Developments and Future Plans
2.10 Verge Genomics
2.10.1 Verge Genomics Details
2.10.2 Verge Genomics Major Business
2.10.3 Verge Genomics Artificial Intelligence Drug R&D Product and Solutions
2.10.4 Verge Genomics Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Verge Genomics Recent Developments and Future Plans
2.11 Iktos
2.11.1 Iktos Details
2.11.2 Iktos Major Business
2.11.3 Iktos Artificial Intelligence Drug R&D Product and Solutions
2.11.4 Iktos Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Iktos Recent Developments and Future Plans
2.12 Valo Health
2.12.1 Valo Health Details
2.12.2 Valo Health Major Business
2.12.3 Valo Health Artificial Intelligence Drug R&D Product and Solutions
2.12.4 Valo Health Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Valo Health Recent Developments and Future Plans
2.13 Standigm
2.13.1 Standigm Details
2.13.2 Standigm Major Business
2.13.3 Standigm Artificial Intelligence Drug R&D Product and Solutions
2.13.4 Standigm Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Standigm Recent Developments and Future Plans
2.14 Relay Therapeutics
2.14.1 Relay Therapeutics Details
2.14.2 Relay Therapeutics Major Business
2.14.3 Relay Therapeutics Artificial Intelligence Drug R&D Product and Solutions
2.14.4 Relay Therapeutics Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Relay Therapeutics Recent Developments and Future Plans
2.15 Cyclica
2.15.1 Cyclica Details
2.15.2 Cyclica Major Business
2.15.3 Cyclica Artificial Intelligence Drug R&D Product and Solutions
2.15.4 Cyclica Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Cyclica Recent Developments and Future Plans
2.16 Isomorphic Labs
2.16.1 Isomorphic Labs Details
2.16.2 Isomorphic Labs Major Business
2.16.3 Isomorphic Labs Artificial Intelligence Drug R&D Product and Solutions
2.16.4 Isomorphic Labs Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Isomorphic Labs Recent Developments and Future Plans
2.17 Schrodinger
2.17.1 Schrodinger Details
2.17.2 Schrodinger Major Business
2.17.3 Schrodinger Artificial Intelligence Drug R&D Product and Solutions
2.17.4 Schrodinger Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Schrodinger Recent Developments and Future Plans
2.18 Absci
2.18.1 Absci Details
2.18.2 Absci Major Business
2.18.3 Absci Artificial Intelligence Drug R&D Product and Solutions
2.18.4 Absci Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Absci Recent Developments and Future Plans
2.19 Genesis Therapeutics
2.19.1 Genesis Therapeutics Details
2.19.2 Genesis Therapeutics Major Business
2.19.3 Genesis Therapeutics Artificial Intelligence Drug R&D Product and Solutions
2.19.4 Genesis Therapeutics Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Genesis Therapeutics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Artificial Intelligence Drug R&D Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Artificial Intelligence Drug R&D by Company Revenue
3.2.2 Top 3 Artificial Intelligence Drug R&D Players Market Share in 2025
3.2.3 Top 6 Artificial Intelligence Drug R&D Players Market Share in 2025
3.3 Artificial Intelligence Drug R&D Market: Overall Company Footprint Analysis
3.3.1 Artificial Intelligence Drug R&D Market: Region Footprint
3.3.2 Artificial Intelligence Drug R&D Market: Company Product Type Footprint
3.3.3 Artificial Intelligence Drug R&D Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Artificial Intelligence Drug R&D Consumption Value and Market Share by Type (2021-2026)
4.2 Global Artificial Intelligence Drug R&D Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2021-2026)
5.2 Global Artificial Intelligence Drug R&D Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Artificial Intelligence Drug R&D Consumption Value by Type (2021-2032)
6.2 North America Artificial Intelligence Drug R&D Market Size by Application (2021-2032)
6.3 North America Artificial Intelligence Drug R&D Market Size by Country
6.3.1 North America Artificial Intelligence Drug R&D Consumption Value by Country (2021-2032)
6.3.2 United States Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
6.3.3 Canada Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
6.3.4 Mexico Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Artificial Intelligence Drug R&D Consumption Value by Type (2021-2032)
7.2 Europe Artificial Intelligence Drug R&D Consumption Value by Application (2021-2032)
7.3 Europe Artificial Intelligence Drug R&D Market Size by Country
7.3.1 Europe Artificial Intelligence Drug R&D Consumption Value by Country (2021-2032)
7.3.2 Germany Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
7.3.3 France Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
7.3.5 Russia Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
7.3.6 Italy Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region
8.3.1 Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Region (2021-2032)
8.3.2 China Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
8.3.3 Japan Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
8.3.4 South Korea Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
8.3.5 India Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
8.3.7 Australia Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Artificial Intelligence Drug R&D Consumption Value by Type (2021-2032)
9.2 South America Artificial Intelligence Drug R&D Consumption Value by Application (2021-2032)
9.3 South America Artificial Intelligence Drug R&D Market Size by Country
9.3.1 South America Artificial Intelligence Drug R&D Consumption Value by Country (2021-2032)
9.3.2 Brazil Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
9.3.3 Argentina Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country
10.3.1 Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Country (2021-2032)
10.3.2 Turkey Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
10.3.4 UAE Artificial Intelligence Drug R&D Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Artificial Intelligence Drug R&D Market Drivers
11.2 Artificial Intelligence Drug R&D Market Restraints
11.3 Artificial Intelligence Drug R&D Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Artificial Intelligence Drug R&D Industry Chain
12.2 Artificial Intelligence Drug R&D Upstream Analysis
12.3 Artificial Intelligence Drug R&D Midstream Analysis
12.4 Artificial Intelligence Drug R&D Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Artificial Intelligence Drug R&D Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Artificial Intelligence Drug R&D Consumption Value by Stage, (USD Million), 2021 & 2025 & 2032
Table 3. Global Artificial Intelligence Drug R&D Consumption Value by Technology, (USD Million), 2021 & 2025 & 2032
Table 4. Global Artificial Intelligence Drug R&D Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Artificial Intelligence Drug R&D Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Artificial Intelligence Drug R&D Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Insilico Medicine Company Information, Head Office, and Major Competitors
Table 8. Insilico Medicine Major Business
Table 9. Insilico Medicine Artificial Intelligence Drug R&D Product and Solutions
Table 10. Insilico Medicine Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Insilico Medicine Recent Developments and Future Plans
Table 12. Recursion Company Information, Head Office, and Major Competitors
Table 13. Recursion Major Business
Table 14. Recursion Artificial Intelligence Drug R&D Product and Solutions
Table 15. Recursion Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Recursion Recent Developments and Future Plans
Table 17. BenevolentAI Company Information, Head Office, and Major Competitors
Table 18. BenevolentAI Major Business
Table 19. BenevolentAI Artificial Intelligence Drug R&D Product and Solutions
Table 20. BenevolentAI Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Atomwise Company Information, Head Office, and Major Competitors
Table 22. Atomwise Major Business
Table 23. Atomwise Artificial Intelligence Drug R&D Product and Solutions
Table 24. Atomwise Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Atomwise Recent Developments and Future Plans
Table 26. Recursion Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 27. Recursion Pharmaceuticals Major Business
Table 28. Recursion Pharmaceuticals Artificial Intelligence Drug R&D Product and Solutions
Table 29. Recursion Pharmaceuticals Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Recursion Pharmaceuticals Recent Developments and Future Plans
Table 31. DeepMind?Google? Company Information, Head Office, and Major Competitors
Table 32. DeepMind?Google? Major Business
Table 33. DeepMind?Google? Artificial Intelligence Drug R&D Product and Solutions
Table 34. DeepMind?Google? Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. DeepMind?Google? Recent Developments and Future Plans
Table 36. Insitro Company Information, Head Office, and Major Competitors
Table 37. Insitro Major Business
Table 38. Insitro Artificial Intelligence Drug R&D Product and Solutions
Table 39. Insitro Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Insitro Recent Developments and Future Plans
Table 41. Owkin Company Information, Head Office, and Major Competitors
Table 42. Owkin Major Business
Table 43. Owkin Artificial Intelligence Drug R&D Product and Solutions
Table 44. Owkin Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Owkin Recent Developments and Future Plans
Table 46. XtalPi Company Information, Head Office, and Major Competitors
Table 47. XtalPi Major Business
Table 48. XtalPi Artificial Intelligence Drug R&D Product and Solutions
Table 49. XtalPi Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. XtalPi Recent Developments and Future Plans
Table 51. Verge Genomics Company Information, Head Office, and Major Competitors
Table 52. Verge Genomics Major Business
Table 53. Verge Genomics Artificial Intelligence Drug R&D Product and Solutions
Table 54. Verge Genomics Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Verge Genomics Recent Developments and Future Plans
Table 56. Iktos Company Information, Head Office, and Major Competitors
Table 57. Iktos Major Business
Table 58. Iktos Artificial Intelligence Drug R&D Product and Solutions
Table 59. Iktos Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Iktos Recent Developments and Future Plans
Table 61. Valo Health Company Information, Head Office, and Major Competitors
Table 62. Valo Health Major Business
Table 63. Valo Health Artificial Intelligence Drug R&D Product and Solutions
Table 64. Valo Health Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Valo Health Recent Developments and Future Plans
Table 66. Standigm Company Information, Head Office, and Major Competitors
Table 67. Standigm Major Business
Table 68. Standigm Artificial Intelligence Drug R&D Product and Solutions
Table 69. Standigm Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Standigm Recent Developments and Future Plans
Table 71. Relay Therapeutics Company Information, Head Office, and Major Competitors
Table 72. Relay Therapeutics Major Business
Table 73. Relay Therapeutics Artificial Intelligence Drug R&D Product and Solutions
Table 74. Relay Therapeutics Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Relay Therapeutics Recent Developments and Future Plans
Table 76. Cyclica Company Information, Head Office, and Major Competitors
Table 77. Cyclica Major Business
Table 78. Cyclica Artificial Intelligence Drug R&D Product and Solutions
Table 79. Cyclica Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Cyclica Recent Developments and Future Plans
Table 81. Isomorphic Labs Company Information, Head Office, and Major Competitors
Table 82. Isomorphic Labs Major Business
Table 83. Isomorphic Labs Artificial Intelligence Drug R&D Product and Solutions
Table 84. Isomorphic Labs Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Isomorphic Labs Recent Developments and Future Plans
Table 86. Schr?dinger Company Information, Head Office, and Major Competitors
Table 87. Schr?dinger Major Business
Table 88. Schr?dinger Artificial Intelligence Drug R&D Product and Solutions
Table 89. Schr?dinger Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Schr?dinger Recent Developments and Future Plans
Table 91. Absci Company Information, Head Office, and Major Competitors
Table 92. Absci Major Business
Table 93. Absci Artificial Intelligence Drug R&D Product and Solutions
Table 94. Absci Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Absci Recent Developments and Future Plans
Table 96. Genesis Therapeutics Company Information, Head Office, and Major Competitors
Table 97. Genesis Therapeutics Major Business
Table 98. Genesis Therapeutics Artificial Intelligence Drug R&D Product and Solutions
Table 99. Genesis Therapeutics Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. Genesis Therapeutics Recent Developments and Future Plans
Table 101. Global Artificial Intelligence Drug R&D Revenue (USD Million) by Players (2021-2026)
Table 102. Global Artificial Intelligence Drug R&D Revenue Share by Players (2021-2026)
Table 103. Breakdown of Artificial Intelligence Drug R&D by Company Type (Tier 1, Tier 2, and Tier 3)
Table 104. Market Position of Players in Artificial Intelligence Drug R&D, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 105. Head Office of Key Artificial Intelligence Drug R&D Players
Table 106. Artificial Intelligence Drug R&D Market: Company Product Type Footprint
Table 107. Artificial Intelligence Drug R&D Market: Company Product Application Footprint
Table 108. Artificial Intelligence Drug R&D New Market Entrants and Barriers to Market Entry
Table 109. Artificial Intelligence Drug R&D Mergers, Acquisition, Agreements, and Collaborations
Table 110. Global Artificial Intelligence Drug R&D Consumption Value (USD Million) by Type (2021-2026)
Table 111. Global Artificial Intelligence Drug R&D Consumption Value Share by Type (2021-2026)
Table 112. Global Artificial Intelligence Drug R&D Consumption Value Forecast by Type (2027-2032)
Table 113. Global Artificial Intelligence Drug R&D Consumption Value by Application (2021-2026)
Table 114. Global Artificial Intelligence Drug R&D Consumption Value Forecast by Application (2027-2032)
Table 115. North America Artificial Intelligence Drug R&D Consumption Value by Type (2021-2026) & (USD Million)
Table 116. North America Artificial Intelligence Drug R&D Consumption Value by Type (2027-2032) & (USD Million)
Table 117. North America Artificial Intelligence Drug R&D Consumption Value by Application (2021-2026) & (USD Million)
Table 118. North America Artificial Intelligence Drug R&D Consumption Value by Application (2027-2032) & (USD Million)
Table 119. North America Artificial Intelligence Drug R&D Consumption Value by Country (2021-2026) & (USD Million)
Table 120. North America Artificial Intelligence Drug R&D Consumption Value by Country (2027-2032) & (USD Million)
Table 121. Europe Artificial Intelligence Drug R&D Consumption Value by Type (2021-2026) & (USD Million)
Table 122. Europe Artificial Intelligence Drug R&D Consumption Value by Type (2027-2032) & (USD Million)
Table 123. Europe Artificial Intelligence Drug R&D Consumption Value by Application (2021-2026) & (USD Million)
Table 124. Europe Artificial Intelligence Drug R&D Consumption Value by Application (2027-2032) & (USD Million)
Table 125. Europe Artificial Intelligence Drug R&D Consumption Value by Country (2021-2026) & (USD Million)
Table 126. Europe Artificial Intelligence Drug R&D Consumption Value by Country (2027-2032) & (USD Million)
Table 127. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Type (2021-2026) & (USD Million)
Table 128. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Type (2027-2032) & (USD Million)
Table 129. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Application (2021-2026) & (USD Million)
Table 130. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Application (2027-2032) & (USD Million)
Table 131. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Region (2021-2026) & (USD Million)
Table 132. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Region (2027-2032) & (USD Million)
Table 133. South America Artificial Intelligence Drug R&D Consumption Value by Type (2021-2026) & (USD Million)
Table 134. South America Artificial Intelligence Drug R&D Consumption Value by Type (2027-2032) & (USD Million)
Table 135. South America Artificial Intelligence Drug R&D Consumption Value by Application (2021-2026) & (USD Million)
Table 136. South America Artificial Intelligence Drug R&D Consumption Value by Application (2027-2032) & (USD Million)
Table 137. South America Artificial Intelligence Drug R&D Consumption Value by Country (2021-2026) & (USD Million)
Table 138. South America Artificial Intelligence Drug R&D Consumption Value by Country (2027-2032) & (USD Million)
Table 139. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Type (2021-2026) & (USD Million)
Table 140. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Type (2027-2032) & (USD Million)
Table 141. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Application (2021-2026) & (USD Million)
Table 142. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Application (2027-2032) & (USD Million)
Table 143. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Country (2021-2026) & (USD Million)
Table 144. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Country (2027-2032) & (USD Million)
Table 145. Global Key Players of Artificial Intelligence Drug R&D Upstream (Raw Materials)
Table 146. Global Artificial Intelligence Drug R&D Typical Customers
Table 1. Global Artificial Intelligence Drug R&D Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Artificial Intelligence Drug R&D Consumption Value by Stage, (USD Million), 2021 & 2025 & 2032
Table 3. Global Artificial Intelligence Drug R&D Consumption Value by Technology, (USD Million), 2021 & 2025 & 2032
Table 4. Global Artificial Intelligence Drug R&D Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Artificial Intelligence Drug R&D Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Artificial Intelligence Drug R&D Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Insilico Medicine Company Information, Head Office, and Major Competitors
Table 8. Insilico Medicine Major Business
Table 9. Insilico Medicine Artificial Intelligence Drug R&D Product and Solutions
Table 10. Insilico Medicine Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Insilico Medicine Recent Developments and Future Plans
Table 12. Recursion Company Information, Head Office, and Major Competitors
Table 13. Recursion Major Business
Table 14. Recursion Artificial Intelligence Drug R&D Product and Solutions
Table 15. Recursion Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Recursion Recent Developments and Future Plans
Table 17. BenevolentAI Company Information, Head Office, and Major Competitors
Table 18. BenevolentAI Major Business
Table 19. BenevolentAI Artificial Intelligence Drug R&D Product and Solutions
Table 20. BenevolentAI Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Atomwise Company Information, Head Office, and Major Competitors
Table 22. Atomwise Major Business
Table 23. Atomwise Artificial Intelligence Drug R&D Product and Solutions
Table 24. Atomwise Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Atomwise Recent Developments and Future Plans
Table 26. Recursion Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 27. Recursion Pharmaceuticals Major Business
Table 28. Recursion Pharmaceuticals Artificial Intelligence Drug R&D Product and Solutions
Table 29. Recursion Pharmaceuticals Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Recursion Pharmaceuticals Recent Developments and Future Plans
Table 31. DeepMind?Google? Company Information, Head Office, and Major Competitors
Table 32. DeepMind?Google? Major Business
Table 33. DeepMind?Google? Artificial Intelligence Drug R&D Product and Solutions
Table 34. DeepMind?Google? Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. DeepMind?Google? Recent Developments and Future Plans
Table 36. Insitro Company Information, Head Office, and Major Competitors
Table 37. Insitro Major Business
Table 38. Insitro Artificial Intelligence Drug R&D Product and Solutions
Table 39. Insitro Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Insitro Recent Developments and Future Plans
Table 41. Owkin Company Information, Head Office, and Major Competitors
Table 42. Owkin Major Business
Table 43. Owkin Artificial Intelligence Drug R&D Product and Solutions
Table 44. Owkin Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Owkin Recent Developments and Future Plans
Table 46. XtalPi Company Information, Head Office, and Major Competitors
Table 47. XtalPi Major Business
Table 48. XtalPi Artificial Intelligence Drug R&D Product and Solutions
Table 49. XtalPi Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. XtalPi Recent Developments and Future Plans
Table 51. Verge Genomics Company Information, Head Office, and Major Competitors
Table 52. Verge Genomics Major Business
Table 53. Verge Genomics Artificial Intelligence Drug R&D Product and Solutions
Table 54. Verge Genomics Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Verge Genomics Recent Developments and Future Plans
Table 56. Iktos Company Information, Head Office, and Major Competitors
Table 57. Iktos Major Business
Table 58. Iktos Artificial Intelligence Drug R&D Product and Solutions
Table 59. Iktos Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Iktos Recent Developments and Future Plans
Table 61. Valo Health Company Information, Head Office, and Major Competitors
Table 62. Valo Health Major Business
Table 63. Valo Health Artificial Intelligence Drug R&D Product and Solutions
Table 64. Valo Health Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Valo Health Recent Developments and Future Plans
Table 66. Standigm Company Information, Head Office, and Major Competitors
Table 67. Standigm Major Business
Table 68. Standigm Artificial Intelligence Drug R&D Product and Solutions
Table 69. Standigm Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Standigm Recent Developments and Future Plans
Table 71. Relay Therapeutics Company Information, Head Office, and Major Competitors
Table 72. Relay Therapeutics Major Business
Table 73. Relay Therapeutics Artificial Intelligence Drug R&D Product and Solutions
Table 74. Relay Therapeutics Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Relay Therapeutics Recent Developments and Future Plans
Table 76. Cyclica Company Information, Head Office, and Major Competitors
Table 77. Cyclica Major Business
Table 78. Cyclica Artificial Intelligence Drug R&D Product and Solutions
Table 79. Cyclica Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Cyclica Recent Developments and Future Plans
Table 81. Isomorphic Labs Company Information, Head Office, and Major Competitors
Table 82. Isomorphic Labs Major Business
Table 83. Isomorphic Labs Artificial Intelligence Drug R&D Product and Solutions
Table 84. Isomorphic Labs Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Isomorphic Labs Recent Developments and Future Plans
Table 86. Schr?dinger Company Information, Head Office, and Major Competitors
Table 87. Schr?dinger Major Business
Table 88. Schr?dinger Artificial Intelligence Drug R&D Product and Solutions
Table 89. Schr?dinger Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Schr?dinger Recent Developments and Future Plans
Table 91. Absci Company Information, Head Office, and Major Competitors
Table 92. Absci Major Business
Table 93. Absci Artificial Intelligence Drug R&D Product and Solutions
Table 94. Absci Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Absci Recent Developments and Future Plans
Table 96. Genesis Therapeutics Company Information, Head Office, and Major Competitors
Table 97. Genesis Therapeutics Major Business
Table 98. Genesis Therapeutics Artificial Intelligence Drug R&D Product and Solutions
Table 99. Genesis Therapeutics Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. Genesis Therapeutics Recent Developments and Future Plans
Table 101. Global Artificial Intelligence Drug R&D Revenue (USD Million) by Players (2021-2026)
Table 102. Global Artificial Intelligence Drug R&D Revenue Share by Players (2021-2026)
Table 103. Breakdown of Artificial Intelligence Drug R&D by Company Type (Tier 1, Tier 2, and Tier 3)
Table 104. Market Position of Players in Artificial Intelligence Drug R&D, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 105. Head Office of Key Artificial Intelligence Drug R&D Players
Table 106. Artificial Intelligence Drug R&D Market: Company Product Type Footprint
Table 107. Artificial Intelligence Drug R&D Market: Company Product Application Footprint
Table 108. Artificial Intelligence Drug R&D New Market Entrants and Barriers to Market Entry
Table 109. Artificial Intelligence Drug R&D Mergers, Acquisition, Agreements, and Collaborations
Table 110. Global Artificial Intelligence Drug R&D Consumption Value (USD Million) by Type (2021-2026)
Table 111. Global Artificial Intelligence Drug R&D Consumption Value Share by Type (2021-2026)
Table 112. Global Artificial Intelligence Drug R&D Consumption Value Forecast by Type (2027-2032)
Table 113. Global Artificial Intelligence Drug R&D Consumption Value by Application (2021-2026)
Table 114. Global Artificial Intelligence Drug R&D Consumption Value Forecast by Application (2027-2032)
Table 115. North America Artificial Intelligence Drug R&D Consumption Value by Type (2021-2026) & (USD Million)
Table 116. North America Artificial Intelligence Drug R&D Consumption Value by Type (2027-2032) & (USD Million)
Table 117. North America Artificial Intelligence Drug R&D Consumption Value by Application (2021-2026) & (USD Million)
Table 118. North America Artificial Intelligence Drug R&D Consumption Value by Application (2027-2032) & (USD Million)
Table 119. North America Artificial Intelligence Drug R&D Consumption Value by Country (2021-2026) & (USD Million)
Table 120. North America Artificial Intelligence Drug R&D Consumption Value by Country (2027-2032) & (USD Million)
Table 121. Europe Artificial Intelligence Drug R&D Consumption Value by Type (2021-2026) & (USD Million)
Table 122. Europe Artificial Intelligence Drug R&D Consumption Value by Type (2027-2032) & (USD Million)
Table 123. Europe Artificial Intelligence Drug R&D Consumption Value by Application (2021-2026) & (USD Million)
Table 124. Europe Artificial Intelligence Drug R&D Consumption Value by Application (2027-2032) & (USD Million)
Table 125. Europe Artificial Intelligence Drug R&D Consumption Value by Country (2021-2026) & (USD Million)
Table 126. Europe Artificial Intelligence Drug R&D Consumption Value by Country (2027-2032) & (USD Million)
Table 127. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Type (2021-2026) & (USD Million)
Table 128. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Type (2027-2032) & (USD Million)
Table 129. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Application (2021-2026) & (USD Million)
Table 130. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Application (2027-2032) & (USD Million)
Table 131. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Region (2021-2026) & (USD Million)
Table 132. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Region (2027-2032) & (USD Million)
Table 133. South America Artificial Intelligence Drug R&D Consumption Value by Type (2021-2026) & (USD Million)
Table 134. South America Artificial Intelligence Drug R&D Consumption Value by Type (2027-2032) & (USD Million)
Table 135. South America Artificial Intelligence Drug R&D Consumption Value by Application (2021-2026) & (USD Million)
Table 136. South America Artificial Intelligence Drug R&D Consumption Value by Application (2027-2032) & (USD Million)
Table 137. South America Artificial Intelligence Drug R&D Consumption Value by Country (2021-2026) & (USD Million)
Table 138. South America Artificial Intelligence Drug R&D Consumption Value by Country (2027-2032) & (USD Million)
Table 139. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Type (2021-2026) & (USD Million)
Table 140. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Type (2027-2032) & (USD Million)
Table 141. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Application (2021-2026) & (USD Million)
Table 142. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Application (2027-2032) & (USD Million)
Table 143. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Country (2021-2026) & (USD Million)
Table 144. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Country (2027-2032) & (USD Million)
Table 145. Global Key Players of Artificial Intelligence Drug R&D Upstream (Raw Materials)
Table 146. Global Artificial Intelligence Drug R&D Typical Customers
LIST OF FIGURES
Figure 1. Artificial Intelligence Drug R&D Picture
Figure 2. Global Artificial Intelligence Drug R&D Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Artificial Intelligence Drug R&D Consumption Value Market Share by Type in 2025
Figure 4. Software
Figure 5. Service
Figure 6. Global Artificial Intelligence Drug R&D Consumption Value by Stage, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Artificial Intelligence Drug R&D Consumption Value Market Share by Stage in 2025
Figure 8. Target Identification & Validation
Figure 9. Hit/Lead Discovery
Figure 10. Clinical Development & Trial Design
Figure 11. Others
Figure 12. Global Artificial Intelligence Drug R&D Consumption Value by Technology, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Artificial Intelligence Drug R&D Consumption Value Market Share by Technology in 2025
Figure 14. Machine Learning & Deep Learning
Figure 15. Generative Models
Figure 16. Knowledge Graph & NLP
Figure 17. Multi-omics / Multimodal Modeling
Figure 18. Global Artificial Intelligence Drug R&D Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Artificial Intelligence Drug R&D Consumption Value Market Share by Application in 2025
Figure 20. Pharmaceutical Companies Picture
Figure 21. Biotechnology Companies Picture
Figure 22. Contract Research Organizations?CRO) Picture
Figure 23. Academic & Research Institutions Picture
Figure 24. Others Picture
Figure 25. Global Artificial Intelligence Drug R&D Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 26. Global Artificial Intelligence Drug R&D Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 27. Global Market Artificial Intelligence Drug R&D Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 28. Global Artificial Intelligence Drug R&D Consumption Value Market Share by Region (2021-2032)
Figure 29. Global Artificial Intelligence Drug R&D Consumption Value Market Share by Region in 2025
Figure 30. North America Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 31. Europe Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 32. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 33. South America Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 34. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 35. Company Three Recent Developments and Future Plans
Figure 36. Global Artificial Intelligence Drug R&D Revenue Share by Players in 2025
Figure 37. Artificial Intelligence Drug R&D Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 38. Market Share of Artificial Intelligence Drug R&D by Player Revenue in 2025
Figure 39. Top 3 Artificial Intelligence Drug R&D Players Market Share in 2025
Figure 40. Top 6 Artificial Intelligence Drug R&D Players Market Share in 2025
Figure 41. Global Artificial Intelligence Drug R&D Consumption Value Share by Type (2021-2026)
Figure 42. Global Artificial Intelligence Drug R&D Market Share Forecast by Type (2027-2032)
Figure 43. Global Artificial Intelligence Drug R&D Consumption Value Share by Application (2021-2026)
Figure 44. Global Artificial Intelligence Drug R&D Market Share Forecast by Application (2027-2032)
Figure 45. North America Artificial Intelligence Drug R&D Consumption Value Market Share by Type (2021-2032)
Figure 46. North America Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2021-2032)
Figure 47. North America Artificial Intelligence Drug R&D Consumption Value Market Share by Country (2021-2032)
Figure 48. United States Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 49. Canada Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 50. Mexico Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 51. Europe Artificial Intelligence Drug R&D Consumption Value Market Share by Type (2021-2032)
Figure 52. Europe Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2021-2032)
Figure 53. Europe Artificial Intelligence Drug R&D Consumption Value Market Share by Country (2021-2032)
Figure 54. Germany Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 55. France Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 56. United Kingdom Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 57. Russia Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 58. Italy Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 59. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value Market Share by Type (2021-2032)
Figure 60. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2021-2032)
Figure 61. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value Market Share by Region (2021-2032)
Figure 62. China Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 63. Japan Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 64. South Korea Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 65. India Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 66. Southeast Asia Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 67. Australia Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 68. South America Artificial Intelligence Drug R&D Consumption Value Market Share by Type (2021-2032)
Figure 69. South America Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2021-2032)
Figure 70. South America Artificial Intelligence Drug R&D Consumption Value Market Share by Country (2021-2032)
Figure 71. Brazil Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 72. Argentina Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 73. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value Market Share by Type (2021-2032)
Figure 74. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2021-2032)
Figure 75. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value Market Share by Country (2021-2032)
Figure 76. Turkey Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 77. Saudi Arabia Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 78. UAE Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 79. Artificial Intelligence Drug R&D Market Drivers
Figure 80. Artificial Intelligence Drug R&D Market Restraints
Figure 81. Artificial Intelligence Drug R&D Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Artificial Intelligence Drug R&D Industrial Chain
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Artificial Intelligence Drug R&D Picture
Figure 2. Global Artificial Intelligence Drug R&D Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Artificial Intelligence Drug R&D Consumption Value Market Share by Type in 2025
Figure 4. Software
Figure 5. Service
Figure 6. Global Artificial Intelligence Drug R&D Consumption Value by Stage, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Artificial Intelligence Drug R&D Consumption Value Market Share by Stage in 2025
Figure 8. Target Identification & Validation
Figure 9. Hit/Lead Discovery
Figure 10. Clinical Development & Trial Design
Figure 11. Others
Figure 12. Global Artificial Intelligence Drug R&D Consumption Value by Technology, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Artificial Intelligence Drug R&D Consumption Value Market Share by Technology in 2025
Figure 14. Machine Learning & Deep Learning
Figure 15. Generative Models
Figure 16. Knowledge Graph & NLP
Figure 17. Multi-omics / Multimodal Modeling
Figure 18. Global Artificial Intelligence Drug R&D Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Artificial Intelligence Drug R&D Consumption Value Market Share by Application in 2025
Figure 20. Pharmaceutical Companies Picture
Figure 21. Biotechnology Companies Picture
Figure 22. Contract Research Organizations?CRO) Picture
Figure 23. Academic & Research Institutions Picture
Figure 24. Others Picture
Figure 25. Global Artificial Intelligence Drug R&D Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 26. Global Artificial Intelligence Drug R&D Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 27. Global Market Artificial Intelligence Drug R&D Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 28. Global Artificial Intelligence Drug R&D Consumption Value Market Share by Region (2021-2032)
Figure 29. Global Artificial Intelligence Drug R&D Consumption Value Market Share by Region in 2025
Figure 30. North America Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 31. Europe Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 32. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 33. South America Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 34. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 35. Company Three Recent Developments and Future Plans
Figure 36. Global Artificial Intelligence Drug R&D Revenue Share by Players in 2025
Figure 37. Artificial Intelligence Drug R&D Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 38. Market Share of Artificial Intelligence Drug R&D by Player Revenue in 2025
Figure 39. Top 3 Artificial Intelligence Drug R&D Players Market Share in 2025
Figure 40. Top 6 Artificial Intelligence Drug R&D Players Market Share in 2025
Figure 41. Global Artificial Intelligence Drug R&D Consumption Value Share by Type (2021-2026)
Figure 42. Global Artificial Intelligence Drug R&D Market Share Forecast by Type (2027-2032)
Figure 43. Global Artificial Intelligence Drug R&D Consumption Value Share by Application (2021-2026)
Figure 44. Global Artificial Intelligence Drug R&D Market Share Forecast by Application (2027-2032)
Figure 45. North America Artificial Intelligence Drug R&D Consumption Value Market Share by Type (2021-2032)
Figure 46. North America Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2021-2032)
Figure 47. North America Artificial Intelligence Drug R&D Consumption Value Market Share by Country (2021-2032)
Figure 48. United States Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 49. Canada Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 50. Mexico Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 51. Europe Artificial Intelligence Drug R&D Consumption Value Market Share by Type (2021-2032)
Figure 52. Europe Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2021-2032)
Figure 53. Europe Artificial Intelligence Drug R&D Consumption Value Market Share by Country (2021-2032)
Figure 54. Germany Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 55. France Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 56. United Kingdom Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 57. Russia Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 58. Italy Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 59. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value Market Share by Type (2021-2032)
Figure 60. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2021-2032)
Figure 61. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value Market Share by Region (2021-2032)
Figure 62. China Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 63. Japan Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 64. South Korea Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 65. India Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 66. Southeast Asia Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 67. Australia Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 68. South America Artificial Intelligence Drug R&D Consumption Value Market Share by Type (2021-2032)
Figure 69. South America Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2021-2032)
Figure 70. South America Artificial Intelligence Drug R&D Consumption Value Market Share by Country (2021-2032)
Figure 71. Brazil Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 72. Argentina Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 73. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value Market Share by Type (2021-2032)
Figure 74. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2021-2032)
Figure 75. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value Market Share by Country (2021-2032)
Figure 76. Turkey Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 77. Saudi Arabia Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 78. UAE Artificial Intelligence Drug R&D Consumption Value (2021-2032) & (USD Million)
Figure 79. Artificial Intelligence Drug R&D Market Drivers
Figure 80. Artificial Intelligence Drug R&D Market Restraints
Figure 81. Artificial Intelligence Drug R&D Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Artificial Intelligence Drug R&D Industrial Chain
Figure 84. Methodology
Figure 85. Research Process and Data Source
